Potential Herb-Drug Pharmacokinetic Interactions between African Wild Olive Leaf Extract and Selected Antihypertensive Drugs^[*]

Abstract

The African wild olive (Olea europaea subsp. africana) is traditionally used as a hypotensive agent. Herb-drug interactions may result from the concurrent use of herbal medicines and conventional prescription drugs. This aspect was investigated by determining the effect of the extract on the in vitro intestinal epithelial permeation of selected hypotensive drugs using the Caco-2 cell culture model. The phytochemical profiles of leaf extracts of African wild olive from different localities in South Africa were compared, since efficacy is determined by the chemical composition. Extracts were analysed using ultra-performance liquid chromatography. The oleuropein concentration varied considerably from below the detection limit (4.94 µg/mL) to 59.4 mg/g dry weight. Chemometric models constructed from the aligned chromatographic data indicated only quantitative differences between the profiles. The leaf extract was found to increase the permeability of propranolol in the absorptive direction (P_app = 8.93 × 10⁻⁶ cm/s) across Caco-2 cell monolayers, but considerably decreased transport in the secretory direction (P_app = 3.68 × 10⁻⁶ cm/s). The permeation of diltiazem was enhanced by the extract in both the absorptive (P_app = 7.33 × 10⁻⁶ cm/s) as well as in the secretory direction (P_app = 7.16 × 10⁻⁶ cm/s), but a decrease in the efflux ratio was observed. The extract therefore caused a net increase in the transport of both drugs in the absorptive direction due to an inhibition effect on their efflux. This suggests a potential increase in the blood levels of these drugs when taken simultaneously with African wild olive leaf extract, indicating potential adverse effects that must be verified in vivo.

Key words

Olea europaea subspecies africana - Oleaceae - herb-drug interaction - oleuropein - antihypertensive drugs - Caco-2 cells

^* Dedicated to Professor Dr. Robert Verpoorte in recognition of his outstanding contribution to natural products research.

• References

• 1 Somova LI, Shode FO, Ramnanan P, Nadar A. Antihypertensive, anti-atherosclerotic and antioxidant activity of triterpenoids from Olea europaea subsp. africana . J Ethnopharmacol 2003; 84: 299-305
• 2 Long H, Tilney P, Van Wyk BE. The ethnobotany and pharmacognosy of Olea europaea subsp. africana (Oleaceae). S Afr J Bot 2010; 76: 324-331
• 3 Cuneo P, Leishman M. African olive (Olea europaea subsp. cuspidata) as an environmental weed in eastern Australia: a review. Cunninghamia 2006; 9: 545-577
• 4 Herman P, Condy G. Olea europaea subsp. africana . Fl Pl Africa 1997; 55: 92-95
• 5 Green P. A revision of Olea L. (Oleaceae). Kew Bull 2002; 57: 91-140
• 6 Van Wyk BE, Van Oudtshoorn B, Gericke N. Medicinal Plants of South Africa. 2nd ed.. ed. Singapore: Tin Wah Press (Pty) Ltd.; 2009
• 7 Petrov V, Manolov P. Pharmacological analysis of the iridoid oleuropein. Arz Forsch (now Drug Res) 1972; 22: 1476-1486
• 8 Petrov V, Manolov P. Pharmacological studies on substances of plant origin with coronary dilating and antiarrhythmic action. Comp Med East West 1978; 6: 123-130
• 9 El SN, Karakaya S. Olive tree (Olea europaea) leaves: potential effects on human health. Nutr Rev 2009; 67: 632-638
• 10 Calitz C, Gouws C, Viljoen J, Steenkamp J, Wiesner L, Abay E, Hamman JH. Herb-drug pharmacokinetic interactions: transport and metabolism of Indinavir in the presence of selected herbal products. Molecules 2015; 20: 22113-22127
• 11 Conference on Harmonisation (ICH). ICH Harmonised Tripartite Guideline – Validation of analytical procedures: text and methodology Q2 (R1). Available at. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/ Accessed June 9, 2016
• 12 Reddy MI, Beotra A, Jain S, Ahi S. A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples. Indian J Pharmacol 2009; 41: 80-86
• 13 Sabry O. Review: beneficial health effects of olive leaves extracts. J Nat Sci Res 2014; 4: 1-9
• 14 Varmuza K, Filzmoser P. Introduction to multivariate statistical Analysis in Chemometrics. Boca Raton: Taylor & Francis Group; 2009
• 15 Matthews SB, Santra M, Mensack MM, Wolfe P, Byrne PF, Thompson HJ. Metabolite profiling of a diverse collection of wheat lines using ultra-performance liquid chromatography coupled with time-of-flight mass spectrometry. PLoS One 2012; 7: e44179
• 16 Wessler JD, Grip LT, Mendell J, Giugliano RP. The P-glycoprotein transport system and cardiovascular drugs. J Am Coll Cardiol 2013; 61: 2495-2502
• 17 Kratz J, Teixeira M, Koester L, Simões C. An HPLC-UV method for the measurement of permeability of marker drugs in the Caco-2 cell assay. Braz J Med Biol Res 2011; 44: 531-537
• 18 Ehrhardt C, Kim K. eds. Drug Absorption Studies: in situ, in vitro and in silico Models. New York: Springer; 2008
• 19 Alvi M, Chatterjee P. A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug. J Am Assoc Pharm Sc 2014; 15: 339-353
• 20 Awortwe C, Fasinu PS, Rosenkranz B. Application of Caco-2 cell line in herb-drug interaction studies: current approaches and challenges. J Pharm Pharm Sci 2014; 17: 1-19
• 21 Miller JN, Miller JC. Statistics and Chemometrics for analytical Chemistry, 6th ed. Gosport, United Kingdom: Ashford Press Ltd.; 2010
• 22 Saha P, Kou J. Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers. Eur J Pharm Biopharm 2000; 50: 403-411
• 23 Quirantes-Pine R, Zurek G, Barrajon-Catalan E, Babmann C, Micol V, Segura-Carretero A, Fernandez-Gutierez A. A metabolite-profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC-ESI-QTOF-MS. J Pharm Biomed Anal 2013; 72: 121-126
• 24 Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011; 77: 275-282
• 25 Zhao W, Uehera S, Tanaka K, Tadokoro S, Kusamori K, Katsumi H, Sakane T, Yamamoto A. Effects of polyoxyethylene alkyl ethers on the intestinal transport and absorption of rhodamine 123: a P-glycoprotein substrate by in vitro and in vivo studies. J Pharm Sci 2016; 105: 1526-1534
• 26 Kotze AF, Luessen HL, De Leeuw BJ, De Boer BG, Verhoef JC, Junginger HE. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release 1998; 51: 35-46
• 27 Hansen TS, Nilsen OG. Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells. Phytother Res 2009; 23: 86-91
• 28 Tarirai C, Viljoen AM, Hamman JH. Herb-drug pharmacokinetic interactions reviewed. Expert Opin Drug Met Toxicol 2010; 6: 1515-1538